Core Viewpoint - A class action lawsuit has been filed against NuScale Power Corporation and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][4]. Group 1: Lawsuit Details - Investors have until April 20, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Oregon [4][10]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in NuScale Class A common stock [4][10]. Group 2: Allegations Against NuScale - NuScale is accused of misrepresenting the capabilities and experience of ENTRA1 Energy LLC, which was supposed to construct power generation facilities using NuScale's technology [5][10]. - ENTRA1 was portrayed as a well-established independent power plant development platform, but it allegedly had no significant experience in building or operating nuclear power projects [6][7]. Group 3: Stock Performance Impact - On November 6, 2025, NuScale reported a dramatic increase in general and administrative expenses from $17 million to $519 million, primarily due to a $495 million payment to ENTRA1 [8]. - Following the disclosure of ENTRA1's lack of experience, NuScale's stock dropped by $4.03 per share, or over 12.4%, from $32.46 to $28.43 between November 6 and November 10, 2025 [8][10].

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against NuScale Power Corporation (NYSE:SMR) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in NuScale, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/nuscale-class-action-l ...

Core Viewpoint - A class action lawsuit has been filed against NuScale Power Corporation and certain senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Oregon, captioned Truedson v. NuScale Power Corporation, et al., No. 3:26-cv-00328 [3]. - Investors have until April 20, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - NuScale Power Corporation specializes in nuclear technology, particularly the NuScale Power Module (NPM), a small modular nuclear reactor designed for energy generation [4]. - The company had established a partnership with ENTRA1 Energy LLC, which was responsible for constructing power generation facilities using NuScale's NPMs [4]. Group 3: Allegations Against ENTRA1 - NuScale allegedly misrepresented ENTRA1's capabilities, claiming it had extensive experience in developing power plants, while in reality, ENTRA1 had never completed any significant projects in nuclear power generation [5][6]. - ENTRA1 was primarily organized to support its principal, Wadie Habboush, rather than to undertake substantial projects [6]. Group 4: Stock Price Impact - On November 6, 2025, NuScale reported a dramatic increase in general and administrative expenses from $17 million in the previous year to $519 million in Q3 2025, largely due to a $495 million payment to ENTRA1 [7]. - Following the disclosure of ENTRA1's lack of experience, NuScale's stock price fell by $4.03 per share, a decline of over 12.4%, from $32.46 on November 6, 2025, to $28.43 on November 10, 2025 [7].

Core Viewpoint - A class action lawsuit has been filed against NuScale Power Corporation and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - NuScale Power Corporation is a nuclear technology company known for its NuScale Power Module (NPM), a small modular nuclear reactor designed for energy generation within larger power plants [4]. Allegations and Background - The lawsuit claims that NuScale misrepresented its partnership with ENTRA1 Energy LLC, asserting that ENTRA1 had extensive capabilities and experience in developing power plants, which was allegedly false [5][6]. - ENTRA1 is described as having no significant experience in building nuclear power projects and primarily supporting the activities of its principal, Wadie Habboush [6]. Financial Impact - On November 6, 2025, NuScale reported a dramatic increase in general and administrative expenses from $17 million in the previous year to $519 million in Q3 2025, largely due to a $495 million payment to ENTRA1 [7]. - Following the disclosure of ENTRA1's lack of experience, NuScale's stock price fell by $4.03 per share, a decline of over 12.4%, from $32.46 to $28.43 between November 6 and November 10, 2025 [7].

Core Points - ACELYRIN, INC. has adopted a limited-duration stockholder rights plan in response to Tang Capital Partners accumulating 8.8% of its outstanding common stock [1][3] - The rights plan aims to maximize stockholder value and is effective immediately, expiring on March 12, 2026 [2][4] Rights Plan Details - Each share of common stock will receive one right, which will become exercisable if any person acquires 10% or more of the company's outstanding common stock [3] - Holders of rights (excluding the acquiring person) can purchase additional shares at a price equal to twice the exercise price [3] - Current owners exceeding the Triggering Percentage can retain their shares but cannot acquire more without triggering the rights plan [3] Company Overview - ACELYRIN focuses on developing transformative medicines in immunology, with its lead program being lonigutamab, a monoclonal antibody for thyroid eye disease [5]